COMBINATION OF ENDOMETRIAL HYPERPLASTIC PROCESSES WITH CHRONIC ENDOMETRITIS
Abstract
Clinical morphological changes causing development of hyperplastic processes of endometrium are reviewed, According authors assumptions genetic modifications may have place in development of malignant processes in women reproductive system (e.g. endometrium cancer, cervical dysplasia etc.). Specific moleculas markers or their combination can evaluate the prognosis of disease development, facilitate optimal treatment tactics and new therapeutical agents development.
About the Authors
I. Fen
ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития России
Russian Federation
Russian Federation
I. S. Sidorova
I.M. Sechenov First Moscow State Medical University (MSMU), State Educational Institution of Higher Professional Training of the Ministry of Healthcare and Social Development
Russian Federation
Russian Federation
I. V. Stanoevich
I.M. Sechenov First Moscow State Medical University (MSMU), State Educational Institution of Higher Professional Training of the Ministry of Healthcare and Social Development
Russian Federation
Russian Federation
A. L. Unanyan
I.M. Sechenov First Moscow State Medical University (MSMU), State Educational Institution of Higher Professional Training of the Ministry of Healthcare and Social Development
Russian Federation
Russian Federation
E. A. Kudrina
I.M. Sechenov First Moscow State Medical University (MSMU), State Educational Institution of Higher Professional Training of the Ministry of Healthcare and Social Development
Russian Federation
Russian Federation
References
1. Ищенко Л.С. Клинико-морфологические аспекты и пути оптимизации терапии хронического эндометрита//Автореф. дисс.... канд. мед. наук. Москва. 2007; 23 с.
2. Перельмутер В.М. Морфологические изменения эндометрия при гиперэстрогении и эндометриальной интраэпителиальной неоплазии.//УДК: 618.14-007.61-018 Сибирский онкологический журнал. 2008. №5 (29) P. 5
3. Сидорова И.С., Станоевич И.В., Кудрина Е.А., Фен И. Клинико-морфологические особенности сочетанных гиперпластических заболеваний матки.//Журнал «Врач» 2010. август -P. 40-41.
4. Сидорова И.С., Макаров И.О., Унанян А.Л. Патогенез и патогенетически обоснованная терапия хронического эндометрита (клиническая лекция). Акушерство, гинекология и репродукция. 2010; 3: 21-24
5. Система генетических и эпигенетических маркеров в диагностике онкологических заболеваний/Под ред. М.А. Пальцева и Д.В. Залетаева. -М.: ОАО «Издательство «Медицина», 2009. -384 с.: ил.
6. Станоевич И.В. Дифференцированный подход к диагностике и лечению гиперплазии эндометрия у женщин позднего репродуктивного и перименопаузального возраста.//Автореф. дисс.... канд. мед. наук. Москва. 2007; 24 с.
7. Шешукова Н.А., Макаров И.О., Овсянникова Т.В. Гиперпластические процессы эндометрия: особенности пролиферативной активности при сочетании с хроническим эндометритом. Акушерство, гинекология и репродукция. 2011; 3: 10-15
8. Arafa M., Kridelka F., Mathias V., Vanbellinghen J.F., Renard I., Foidart J.M., Boniver J., Delvenne P. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Histopathology. 2008 Nov; 53(5): 525-32.
9. Bozdogan O., Atasoy P., Erekul S., Bozdogan N., Bayram M. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.//Int J Gynecol Pathol. -2002. -Vol. 21, №4. -P. 375-382.
10. Fiegl H., Gattringer C., Widschwendter A. et al. Methylated DNA Collected by Tampons-A New Tool to Detect Endometrial Cancer//Cancer Epidemiology, Biomarkers & Prevention. -2004; 13: 882.
11. Kim S.N., You K.T., Kim H.G. Identification of Target Genes in the Endometri-Al Carcinomas With Microsatellite Mutator Phe-Notype//Int. J. Gynecological Cancer. -2005; 15 (Is.): 126.
12. Nieminen T.T., Gylling A., Abdel-Rahman W.M., Nuorva K., Aarnio M., Renkonen-Sinisalo L., J rvinen H.J., Mecklin J.P., B tzow R., Peltomki P.//Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia. Clin Cancer Res. 2009 Sep 15; 15(18): 5772-83.
13. Yoshida H., Broaddus R.,Cheng W. et al. Deregulation of the H0XA10 Homeobox Gene in Endometrial Carcinoma: Role in Epithelial Mesenchymal Transition//Cancer Res. -2006; 66: 889.
14. Yutaka S., Okada T., Anno K. et al. Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation//Clinical Cancer Research. -2008; 14; 3354.
Review
For citations:
Fen I., Sidorova I.S., Stanoevich I.V., Unanyan A.L., Kudrina E.A. COMBINATION OF ENDOMETRIAL HYPERPLASTIC PROCESSES WITH CHRONIC ENDOMETRITIS. Obstetrics, Gynecology and Reproduction. 2012;6(1):31-33. (In Russ.)
Views: 405
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
